CVS - CVS Health Corporation

NYSE - NYSE Delayed price. Currency in USD
74.92
-0.43 (-0.57%)
At close: 4:00PM EST

74.92 0.00 (0.00%)
After hours: 5:04PM EST

Stock chart is not supported by your current browser
Previous close75.35
Open75.25
Bid74.93 x 800
Ask75.05 x 900
Day's range74.34 - 75.49
52-week range51.72 - 81.65
Volume6,170,342
Avg. volume7,097,343
Market cap97.468B
Beta (3Y monthly)0.84
PE ratio (TTM)21.10
EPS (TTM)3.55
Earnings date18 Feb 2020 - 24 Feb 2020
Forward dividend & yield2.00 (2.65%)
Ex-dividend date2019-10-23
1y target est78.35
  • CVS Health CEO Merlo: 2020 Strategy Driven by Data, Customers
    Bloomberg

    CVS Health CEO Merlo: 2020 Strategy Driven by Data, Customers

    Nov.07 -- CVS Health President and Chief Executive Officer Larry Merlo talks with Bloomberg’s Drew Armstrong at The Year Ahead Summit in New York about the health care landscape for 2020.

  • Should You Be Concerned About CVS Health Corporation's (NYSE:CVS) ROE?
    Simply Wall St.

    Should You Be Concerned About CVS Health Corporation's (NYSE:CVS) ROE?

    One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

  • The Extreme Risks of Trading Your Own Retirement Assets - November 15, 2019
    Zacks

    The Extreme Risks of Trading Your Own Retirement Assets - November 15, 2019

    From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.

  • 3 REITs for Dividend Investors to Buy with Stock Market at New Highs
    Zacks

    3 REITs for Dividend Investors to Buy with Stock Market at New Highs

    Here are three highly-ranked REITs we found using our Zacks Stock Screener that dividend investors might want to buy with stock indexes at new highs...

  • Here's Why You Should Hold on to CVS Health (CVS) For Now
    Zacks

    Here's Why You Should Hold on to CVS Health (CVS) For Now

    Investors can still hold on to CVS Health (CVS) stock, thanks to its solid prospects.

  • Walgreens Boots Rallies on KKR's Bid but Market View Mixed
    Zacks

    Walgreens Boots Rallies on KKR's Bid but Market View Mixed

    Albeit the market sentiment is bullish on Walgreens Boots' (WBA) potential acquisition deal, many analysts are in doubt about the company's effective approach to get privatized.

  • CVS Health's New Plans With Aetna May Improve Health Outcomes
    Zacks

    CVS Health's New Plans With Aetna May Improve Health Outcomes

    CVS Health's (CVS) Health Care Benefits segment develops Medicare program with Aetna.

  • Want To Retire Early? Learn the Intelligent Investing Secret - November 13, 2019
    Zacks

    Want To Retire Early? Learn the Intelligent Investing Secret - November 13, 2019

    Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.

  • CVS Health's Aetna Prospects Solid, Omnicare Sluggish
    Zacks

    CVS Health's Aetna Prospects Solid, Omnicare Sluggish

    CVS Health's (CVS) strong Pharmacy Services segment sales gain traction from growth in specialty services.

  • The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health
    Zacks

    The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health

    The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health

  • Top Analyst Reports for Mastercard, UnitedHealth & Merck
    Zacks

    Top Analyst Reports for Mastercard, UnitedHealth & Merck

    Top Analyst Reports for Mastercard, UnitedHealth & Merck

  • Stock Market News for Nov 7, 2019
    Zacks

    Stock Market News for Nov 7, 2019

    Wall Street moved negligibly on Nov 6 as stocks struggled to sustain the rally earlier in the week.

  • The Extreme Risks of Trading Your Own Retirement Assets - November 07, 2019
    Zacks

    The Extreme Risks of Trading Your Own Retirement Assets - November 07, 2019

    From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.

  • CVS Health (CVS) Beats on Q3 Earnings, Raises '19 EPS Guidance
    Zacks

    CVS Health (CVS) Beats on Q3 Earnings, Raises '19 EPS Guidance

    CVS Health's (CVS) strong year-over-year growth in the top line is aided by a robust performance at the Pharmacy Services segment.

  • Economic Data Deluge
    Zacks

    Economic Data Deluge

    Economic Data Deluge

  • Q3 Productivity Slips to -0.3%, Labor Costs Rise 3.6%
    Zacks

    Q3 Productivity Slips to -0.3%, Labor Costs Rise 3.6%

    To see a negative headline read on U.S. Productivity is thankfully quite rare. The last time we saw this was nearly 4 full years ago.

  • CVS Raises Forecast as Drug Services, Retail Segments Gain
    Bloomberg

    CVS Raises Forecast as Drug Services, Retail Segments Gain

    (Bloomberg) -- CVS Health Corp. raised its 2019 profit forecast after the reporting strong results across its pharmacy services, health insurance and drugstore segments for the third quarter.After beating analysts’ estimates, CVS said its 2019 adjusted earnings will be to $6.97 to $7.05 a share, up from $6.89 to $7.00. For more details on the results, click here.Key InsightsDespite ongoing pressure from politicians and consumers on drug prices in the U.S., including the role of companies like CVS that manage patients’ pharmacy benefits, the PBM unit is performing well. Revenue at the business, called Caremark, was up 6.4%, and adjusted operating income rose 5.7% to $1.44 billion. “The debate has now shifted not on the PBMs, but to the manufacturers in terms of why are the list prices what they are,” Chief Executive Officer Larry Merlo said on a conference call with analysts.At the company’s brick-and-mortar pharmacies, retail sales rose -- good news in an industry that’s been beset by pressure from online competitors. Front-of-store revenue was up from a year ago, thanks to sales of beauty products and over-the-counter cold and cough medicine.The health-insurance business CVS acquired with its takeover of Aetna last year is proving highly profitable: it reported better margins than the retail and pharmacy benefits segments.Know MoreThe shares gained 4.8% to $70.55 at 10:12 a.m. in New York, and Woonsocket, Rhode Island-based CVS is up almost 3% this year as of Tuesday’s close. That’s far better than the 10% decline by its biggest drugstore rival, Walgreens Boots Alliance Inc., which Bloomberg reported Tuesday is reviewing a possible leveraged buyout with private equity firms.CVS has been transforming some of its stores into “health hubs,” transitioning retail floor space into areas where customers can get medical and other health services. The move is a part of CVS’s shift from a retail drugstore chain to focus more on integrated health-care services in the wake of its acquisition Aetna.Net income in the third quarter was $1.53 billion, up from $1.39 billion a year prior.To read the company’s press release, click here.(Updates with opening share price in “Know More” section)To contact the reporter on this story: Robert Langreth in New York at rlangreth@bloomberg.netTo contact the editor responsible for this story: Drew Armstrong at darmstrong17@bloomberg.netFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • Stock market news: November 6, 2019
    Yahoo Finance

    Stock market news: November 6, 2019

    Stocks pared losses and ended mixed after a report from Reuters that a meeting between President Donald Trump and China’s Xi Jinping could be pushed back until December.

  • CVS Keeps Beating Estimates, Raises Earnings Outlook
    Market Realist

    CVS Keeps Beating Estimates, Raises Earnings Outlook

    CVS Health (CVS) again beat analysts' revenue and EPS estimates when it released its Q3 earnings today. Its stock was up about 3% in premarket trading.

  • Reuters - UK Focus

    US STOCKS-Wall St near highs after upbeat earnings run

    Wall Street was on course to open close to record highs on Wednesday as investors digested a corporate earnings season that has seen the bulk of U.S.-listed firms best analysts' expectations, funding another round of stock market gains. CVS Health Corp gained 2.6% in premarket trading after the pharmacy chain posted a better-than-expected quarterly profit, partly boosted by its pharmacy benefit management unit.

  • CVS Health (CVS) Q3 Earnings and Revenues Top Estimates
    Zacks

    CVS Health (CVS) Q3 Earnings and Revenues Top Estimates

    CVS Health (CVS) delivered earnings and revenue surprises of 3.95% and 2.83%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Why Walgreens Is Mulling Over Going Private
    Market Realist

    Why Walgreens Is Mulling Over Going Private

    Reuters reports that Walgreens Boots Alliance (WBA) is exploring options to go private and has engaged Evercore Partners to put together a deal.

  • CVS quarterly profit beats expectations; shares rise as it eyes growth
    Reuters

    CVS quarterly profit beats expectations; shares rise as it eyes growth

    "We believe if we can engage consumers around their health, we will improve health outcomes and ultimately that will reduce healthcare costs," Chief Executive Larry Merlo said in a phone interview. The hubs are already driving prescription growth and retail store sales, Merlo said. Merlo expects to provide more financial details around the second quarter of next year.

  • Morningstar

    CVS Turns in Strong Third Quarter, Boosts 2019 Outlook

    We view shares of the narrow-moat firm as undervalued.

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more